Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
Research article (American Journal of Psychiatry, 2021) · cited 80× · AI/ML